Investor information
The innovative start-up company EderaGen AS was established at the turn of the year 2017-18 by professor emeritus Jan Raa and his long-term business partner Knut Eirik Andersen, who are jointly leading the scientific, technological and commercial development of the Company. The 100% owned sales subsidiary EderaGen Helse AS is dedicated to food supplements for strengthening innate immunity and for gut health. The unique gut health invention of EderaGen AS is protected by a Norwegian patent titled “Deconstructed soil composition”, issued in 2023.
Following a June 2025 emission of stock at a share premium, the share capital is NOK 2,906,505. As per January 2026, EderaGen AS has 45 shareholders. International patents on the “Deconstructed soil composition” were issued in second half of 2025, in Japan, the United States and Canada, respectively.
The Company is now implementing the activities financed by the 2025 emission of stock. It is expected that a successful expansion will form the basis for another emission of stock by mid-2027.
In the interim, investors may contact the CEO at kea@ederagen.no.
